Abstract
An outbreak of pneumonia, caused by a novel coronavirus (COVID-19) was Identified in China in Dec 2019. This virus expanded worldwide, causing global concern. Clinical, laboratory and imaging features of this infection are characterized in some observational studies. We undertook a systematic review and meta-analysis to assess the frequency of clinical, laboratory, and CT features in COVID-19 patients.
We did a systematic review and meta-analysis using three databases to identify clinical, laboratory, and CT features of rRT-PCR confirmed cases of COVID-19. Data for 3420 patients from 30 observational studies were included.
Overall, the results showed that fever (84.2%, 95%CI 82.6-85.7), cough (62%, 95%CI 60-64), and fatigue (39.4%, 95%CI 37.2-41.6%) were the most prevalent symptoms in COVID-19 patients. Increased CRP level, decreased lymphocyte count, and increased D-dimer level were the most common laboratory findings. Among COVID-19 patients, 92% had a positive CT finding, most prevalently GGO (60%, 95%CI 58-62) and peripheral distribution (64%, 95%CI 60-69).
These results demonstrate the clinical, paraclinical, and imaging features of COIVD-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding supported this study.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
-
Abbreviations
- COVID-19
- Corona Virus Disease of 2019
- rRT-PCR
- real-time Reverse Transcription–Polymerase Chain Reaction
- CT-scan
- Computed Tomography scan
- CI
- Confidence Intervals
- CRP
- C-Reactive Protein
- RNA
- Ribonucleic Acid
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Corona Virus #2
- PRISMA
- protocol based on transparent reporting of systematic reviews and meta-analysis
- CBC
- Complete Blood Count
- CMA
- comprehensive meta-analysis
- GGO
- ground-glass opacities
- β-CoV
- beta coronavirus
- MERS
- Middle Eastern Respiratory Syndrome
- SARS
- Severe Acute Respiratory Syndrome
- LDH
- Lactate Dehydrogenase
- WBC
- White Blood Cell
- ALT
- Alanine Transaminase
- AST
- Aspartate Aminotransferase
- INR
- International Normalized Ratio.
